APA način citiranja (7. izdanje)

Chunxia, Q., Meiyun, H., Leiming, G., Ming, L., Zhou, L., Jing, G., . . . Beifen, S. (2012). Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation. BMC.

Čikaški stil citiranja (17. izdanje)

Chunxia, Qiao, et al. Structural Basis of LaDR5, a Novel Agonistic Anti-death Receptor 5 (DR5) Monoclonal Antibody, to Inhibit DR5/TRAIL Complex Formation. BMC, 2012.

MLA način citiranja (9. izdanje)

Chunxia, Qiao, et al. Structural Basis of LaDR5, a Novel Agonistic Anti-death Receptor 5 (DR5) Monoclonal Antibody, to Inhibit DR5/TRAIL Complex Formation. BMC, 2012.